Skip to main content

ADVERTISEMENT

Antonio Rapacciuolo, MD

Original Contribution
05/29/2012
Abstract: Background. To evaluate the safety and efficacy of unrestricted Endeavor Resolute zotarolimus-eluting stent (ZES) use. Furthermore, we sought to evaluate clinical outcomes associated with on- and off-label use of Resolute ZES....
Abstract: Background. To evaluate the safety and efficacy of unrestricted Endeavor Resolute zotarolimus-eluting stent (ZES) use. Furthermore, we sought to evaluate clinical outcomes associated with on- and off-label use of Resolute ZES....
Abstract: Background. To...
05/29/2012
Journal of Invasive Cardiology